222 related articles for article (PubMed ID: 32915373)
41. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
42. A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.
Won YW; Joo J; Yun T; Lee GK; Han JY; Kim HT; Lee JS; Kim MS; Lee JM; Lee HS; Zo JI; Kim S
Lung Cancer; 2015 May; 88(2):201-7. PubMed ID: 25726044
[TBL] [Abstract][Full Text] [Related]
43. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.
Liu L; Zhang J; Zhao K; Guo C; Huang C; Li S; Chen Y
Orphanet J Rare Dis; 2024 Jun; 19(1):232. PubMed ID: 38863016
[TBL] [Abstract][Full Text] [Related]
45. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
46. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320
[TBL] [Abstract][Full Text] [Related]
47. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
48. Development and External Validation of a Simplified Nomogram Predicting Individual Survival After R0 Resection for Gastric Cancer: An International, Multicenter Study.
Zheng ZF; Lu J; Wang W; Desiderio J; Li P; Xie JW; Wang JB; Lin JX; Parisi A; Zhou ZW; Huang CM; Zheng CH
Ann Surg Oncol; 2018 Aug; 25(8):2383-2390. PubMed ID: 29881929
[TBL] [Abstract][Full Text] [Related]
49. Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
Yamagata Y; Yoshikawa T; Ishizu K; Kamiya A; Wada T; Hayashi T; Otsuki S; Katai H
Eur J Surg Oncol; 2021 Aug; 47(8):2004-2009. PubMed ID: 33408057
[TBL] [Abstract][Full Text] [Related]
50. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
[TBL] [Abstract][Full Text] [Related]
51. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.
Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T
Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559
[TBL] [Abstract][Full Text] [Related]
52. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
53. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
54. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
[TBL] [Abstract][Full Text] [Related]
55. Gastric mixed adenoneuroendocrine carcinoma with thyroid transcription factor-1-positive neuroendocrine component.
Yamaguchi E; Sato Y; Oe T; Nishi T; Koike M; Kitakado Y; Takubo K
Clin J Gastroenterol; 2015 Apr; 8(2):82-7. PubMed ID: 25823931
[TBL] [Abstract][Full Text] [Related]
56. Prediction of recurrence of early gastric cancer after curative resection.
Lai JF; Kim S; Kim K; Li C; Oh SJ; Hyung WJ; Rha SY; Chung HC; Choi SH; Wang LB; Noh SH
Ann Surg Oncol; 2009 Jul; 16(7):1896-902. PubMed ID: 19434457
[TBL] [Abstract][Full Text] [Related]
57. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM
World J Surg; 2021 Jul; 45(7):2134-2141. PubMed ID: 33768309
[TBL] [Abstract][Full Text] [Related]
58. Validation of a Nomogram to Predict Long Term Outcomes After Curative Surgery for Gastric Cancer in an Italian Cohort of Patients.
Capelli G; Tonello AS; Chiminazzo V; Lorenzoni G; Bao QR; Marchet A; Gregori D; Pawlik TM; Pucciarelli S; Spolverato G
J Visc Surg; 2022 Dec; 159(6):471-479. PubMed ID: 34794901
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
60. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
